Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Cyclacel Pharmaceuticals - 21 Year Stock Price History | CYCC

Historical daily share price chart and data for Cyclacel Pharmaceuticals since 2004 adjusted for splits and dividends. The latest closing stock price for Cyclacel Pharmaceuticals as of May 09, 2025 is 0.25.
  • The all-time high Cyclacel Pharmaceuticals stock closing price was 906978.00 on March 24, 2004.
  • The Cyclacel Pharmaceuticals 52-week high stock price is 3.08, which is 1132% above the current share price.
  • The Cyclacel Pharmaceuticals 52-week low stock price is 0.17, which is 32% below the current share price.
  • The average Cyclacel Pharmaceuticals stock price for the last 52 weeks is 0.87.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Cyclacel Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.1635 0.1759 0.3540 0.0892 0.2534 42.12%
2024 0.7497 1.2567 1.5792 0.1505 0.1783 -85.92%
2023 4.1398 4.9269 8.1806 1.2662 1.2662 -73.31%
2022 13.2619 31.6554 31.6554 3.8435 4.7448 -82.85%
2021 43.4225 56.6952 72.2738 23.0479 27.6718 -50.19%
2020 45.7683 95.2025 130.1780 22.8345 55.5570 -41.72%
2019 86.3222 98.5941 142.2710 47.5898 95.3218 10.74%
2018 200.7335 250.3980 257.5110 79.6719 86.0741 -65.23%
2017 476.4579 778.2240 1162.3600 226.2110 247.5520 -67.11%
2016 695.3645 836.4750 1178.0100 462.3820 752.6150 -11.82%
2015 1220.9451 1194.9600 2884.9900 822.8180 853.5460 -28.56%
2014 5541.0092 7118.5800 7937.9800 1160.4800 1194.7900 -82.59%
2013 7116.7956 10242.6000 10242.6000 4779.8600 6862.5100 -33.66%
2012 7580.6132 6706.1400 12956.8000 5138.3600 10345.0000 46.73%
2011 12790.1296 18044.0000 20314.4000 4660.3600 7050.2900 -59.86%
2010 22858.8298 12427.7000 35371.0000 12069.2000 17566.0000 41.35%
2009 9144.9784 4779.8600 17327.0000 3047.1600 12427.7000 147.62%
2008 26345.6255 64289.1000 64289.1000 3226.4100 5018.8500 -92.34%
2007 79265.4629 83169.5000 106352.0000 59150.7000 65484.1000 -20.12%
2006 77826.2791 83647.6000 100377.0000 55231.4000 81974.6000 2.39%
2005 111423.5813 339370.0000 339370.0000 32264.1000 80062.8000 -75.72%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.053B $0.000B
CYCLACEL is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and cutaneous T-cell lymphoma. Seliciclib (CYC202 or R-roscovitine), a CDK inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $209.551B 15.64
Amgen (AMGN) United States $142.955B 12.81
Gilead Sciences (GILD) United States $120.549B 12.52
Vertex Pharmaceuticals (VRTX) United States $109.136B 0.00
Bristol Myers Squibb (BMY) United States $94.530B 6.33
GSK (GSK) United Kingdom $75.556B 8.98
CSL (CSLLY) Australia $74.278B 0.00
Regeneron Pharmaceuticals (REGN) United States $56.982B 13.83
Argenex SE (ARGX) Netherlands $33.561B 91.61
Alnylam Pharmaceuticals (ALNY) United States $32.747B 0.00
BeiGene (ONC) Cayman Islands $22.978B 0.00
BioNTech SE (BNTX) Germany $22.301B 0.00
Royalty Pharma (RPRX) United States $19.109B 7.87
Biogen (BIIB) United States $17.315B 7.47
Genmab (GNMSF) Denmark $12.761B 13.05
Genmab (GMAB) Denmark $12.414B 13.93
Illumina (ILMN) United States $11.990B 22.75
Insmed (INSM) United States $11.854B 0.00
Incyte (INCY) United States $11.417B 86.74
BioMarin Pharmaceutical (BMRN) United States $11.288B 18.34
Swedish Orphan Biovitrum (BIOVF) Sweden $10.858B 27.73
Exelixis (EXEL) United States $9.968B 20.67
Exact Sciences (EXAS) United States $9.739B 0.00
Moderna (MRNA) United States $9.378B 0.00
QIAGEN (QGEN) Netherlands $9.305B 18.10
Ascendis Pharma (ASND) Denmark $9.222B 0.00
Halozyme Therapeutics (HALO) United States $8.117B 15.53
Bio-Techne Corp (TECH) United States $7.829B 29.20
Roivant Sciences (ROIV) United Kingdom $7.592B 0.00
Revolution Medicines (RVMD) United States $7.529B 0.00
Repligen (RGEN) United States $6.924B 77.51
Bio-Rad Laboratories (BIO.B) United States $6.566B 22.20
Blueprint Medicines (BPMC) United States $6.275B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.026B 5.81
Legend Biotech (LEGN) United States $5.836B 0.00
Telix Pharmaceuticals (TLX) Australia $5.805B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $5.381B 0.00
TG Therapeutics (TGTX) United States $5.341B 140.17
Axsome Therapeutics (AXSM) United States $5.306B 0.00
Guardant Health (GH) United States $5.169B 0.00
Nuvalent (NUVL) United States $5.001B 0.00
Alkermes (ALKS) Ireland $4.968B 13.33
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $4.763B 0.00
ADMA Biologics Inc (ADMA) United States $4.748B 35.68
Zealand Pharma (ZLDPF) Denmark $4.573B 0.00
Vaxcyte (PCVX) United States $4.020B 0.00
Krystal Biotech (KRYS) United States $3.820B 29.44
Cytokinetics (CYTK) United States $3.785B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.651B 0.00
Sarepta Therapeutics (SRPT) United States $3.565B 0.00
PTC Therapeutics (PTCT) United States $3.506B 6.10
SpringWorks Therapeutics (SWTX) United States $3.469B 0.00
Avidity Biosciences (RNA) United States $3.359B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.319B 0.00
Zai Lab (ZLAB) China $3.226B 0.00
Akero Therapeutics (AKRO) United States $3.175B 0.00
Arcellx (ACLX) United States $3.171B 0.00
Viking Therapeutics (VKTX) United States $3.094B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.076B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.919B 25.65
Alvotech (ALVO) Luxembourg $2.918B 16.69
Scholar Rock Holding (SRRK) United States $2.909B 0.00
Merus (MRUS) Netherlands $2.831B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.682B 0.00
Protagonist Therapeutics (PTGX) United States $2.663B 57.29
Metsera (MTSR) United States $2.508B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.477B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.463B 0.00
Immunovant (IMVT) United States $2.381B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.193B 0.00
Apellis Pharmaceuticals (APLS) United States $2.174B 0.00
Ascentage Pharma Group - (AAPG) China $2.117B 0.00
Vericel (VCEL) United States $2.101B 1391.00
Denali Therapeutics (DNLI) United States $2.088B 0.00
Biohaven (BHVN) United States $2.066B 0.00
Ligand Pharmaceuticals (LGND) United States $2.014B 0.00
Kymera Therapeutics (KYMR) United States $1.958B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.955B 13.00
Bavarian Nordic (BVNRY) Denmark $1.952B 10.31
Belite Bio (BLTE) United States $1.945B 0.00
Certara (CERT) United States $1.944B 36.30
NovoCure (NVCR) Jersey $1.938B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.899B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.881B 0.00
Twist Bioscience (TWST) United States $1.847B 0.00
Amicus Therapeutics (FOLD) United States $1.841B 199.33
ImmunityBio (IBRX) United States $1.827B 0.00
CG Oncology (CGON) United States $1.810B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.789B 0.00
Travere Therapeutics (TVTX) United States $1.778B 0.00
Beam Therapeutics (BEAM) United States $1.751B 0.00
Apogee Therapeutics (APGE) United States $1.674B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.613B 0.00
Agios Pharmaceuticals (AGIO) United States $1.582B 0.00
Edgewise Therapeutics (EWTX) United States $1.534B 0.00
Disc Medicine (IRON) United States $1.529B 0.00
IDEAYA Biosciences (IDYA) United States $1.526B 0.00
Janux Therapeutics (JANX) United States $1.513B 0.00
Structure Therapeutics (GPCR) United States $1.466B 0.00
ANI Pharmaceuticals (ANIP) United States $1.444B 14.80
Immunocore Holdings (IMCR) United Kingdom $1.422B 0.00
Mesoblast (MESO) Australia $1.402B 0.00
MannKind (MNKD) United States $1.386B 28.50
Vera Therapeutics (VERA) United States $1.384B 0.00
Adaptive Biotechnologies (ADPT) United States $1.372B 0.00
Liquidia Technologies (LQDA) United States $1.304B 0.00
GRAIL (GRAL) United States $1.242B 0.00
Celldex Therapeutics (CLDX) United States $1.217B 0.00
Pacira BioSciences (PCRX) United States $1.163B 11.07
Dynavax Technologies (DVAX) United States $1.130B 67.21
89BIO (ETNB) United States $1.124B 0.00
BGM Group (BGM) China $1.072B 0.00
MiMedx (MDXG) United States $1.041B 25.18
NeoGenomics (NEO) United States $1.036B 0.00
WAVE Life Sciences (WVE) Singapore $1.015B 0.00
Viridian Therapeutics (VRDN) United States $1.011B 0.00
Novavax (NVAX) United States $0.968B 2.25
Mineralys Therapeutics (MLYS) United States $0.950B 0.00
Anbio Biotechnology (NNNN) Germany $0.925B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.921B 0.00
Gyre Therapeutics (GYRE) United States $0.893B 238.25
Pharvaris (PHVS) Netherlands $0.888B 0.00
Arcus Biosciences (RCUS) United States $0.877B 0.00
Spyre Therapeutics (SYRE) United States $0.850B 0.00
Intellia Therapeutics (NTLA) United States $0.841B 0.00
Oculis Holding AG (OCS) Switzerland $0.811B 0.00
CorMedix Inc (CRMD) United States $0.791B 53.00
Zymeworks (ZYME) United States $0.787B 0.00
Praxis Precision Medicines (PRAX) United States $0.781B 0.00
CureVac (CVAC) Germany $0.778B 4.23
Geron (GERN) United States $0.752B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.746B 0.00
LENZ Therapeutics (LENZ) United States $0.741B 0.00
Nurix Therapeutics (NRIX) United States $0.724B 0.00
Nuvation Bio (NUVB) United States $0.708B 0.00
Bicara Therapeutics (BCAX) United States $0.707B 0.00
Niagen Bioscience (NAGE) United States $0.705B 99.44
Anavex Life Sciences (AVXL) United States $0.704B 0.00
Vir Biotechnology (VIR) United States $0.703B 0.00
UniQure (QURE) Netherlands $0.701B 0.00
ArriVent BioPharma (AVBP) United States $0.686B 0.00
Pharming Group (PHAR) Netherlands $0.682B 0.00
Trevi Therapeutics (TRVI) United States $0.659B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.654B 0.00
Immunome (IMNM) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Dianthus Therapeutics (DNTH) United States $0.629B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
Arbutus Biopharma (ABUS) United States $0.618B 0.00
Pharming Group (PHGUF) Netherlands $0.613B 0.00
AbCellera Biologics (ABCL) Canada $0.606B 0.00
Replimune (REPL) United States $0.594B 0.00
Iovance Biotherapeutics (IOVA) United States $0.584B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.578B 0.00
AnaptysBio (ANAB) United States $0.576B 0.00
Fortrea Holdings (FTRE) United States $0.557B 18.09
Keros Therapeutics (KROS) United States $0.554B 0.00
Cogent Biosciences (COGT) United States $0.548B 0.00
Sionna Therapeutics (SION) United States $0.544B 0.00
GH Research (GHRS) Ireland $0.540B 0.00
Tyra Biosciences (TYRA) United States $0.536B 0.00
Opthea (OPT) Australia $0.525B 0.00
Immatics (IMTX) Germany $0.515B 30.29
Stoke Therapeutics (STOK) United States $0.511B 0.00
Kura Oncology (KURA) United States $0.499B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.486B 0.00
Castle Biosciences (CSTL) United States $0.485B 32.91
Arvinas (ARVN) United States $0.482B 0.00
Urogen Pharma (URGN) United States $0.479B 0.00
Upstream Bio (UPB) United States $0.474B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.464B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.450B 0.00
Eton Pharmaceuticals (ETON) United States $0.450B 0.00
Cullinan Therapeutics (CGEM) United States $0.445B 0.00
MeiraGTx Holdings (MGTX) United States $0.433B 0.00
Abivax SA (ABVX) France $0.426B 0.00
Maze Therapeutics (MAZE) United States $0.421B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.416B 0.00
Sage Therapeutics (SAGE) United States $0.411B 0.00
Sana Biotechnology (SANA) United States $0.410B 0.00
PureTech Health (PRTC) United States $0.403B 0.00
Prothena (PRTA) Ireland $0.400B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.400B 0.00
Northwest Biotherapeutics (NWBO) United States $0.396B 0.00
Kamada (KMDA) Israel $0.395B 26.46
Erasca (ERAS) United States $0.394B 0.00
Precigen (PGEN) United States $0.393B 0.00
Celcuity (CELC) United States $0.384B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.383B 0.00
Zenas BioPharma (ZBIO) United States $0.379B 0.00
REGENXBIO (RGNX) United States $0.377B 0.00
Rapport Therapeutics (RAPP) United States $0.374B 0.00
Alpha Teknova (TKNO) United States $0.372B 0.00
MBX Biosciences (MBX) United States $0.371B 0.00
Cytek Biosciences (CTKB) United States $0.370B 0.00
Verastem (VSTM) United States $0.369B 0.00
Tectonic Therapeutic (TECX) United States $0.369B 0.00
Oric Pharmaceuticals (ORIC) United States $0.361B 0.00
Myriad Genetics (MYGN) United States $0.359B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.351B 0.00
Absci (ABSI) United States $0.351B 0.00
Checkpoint Therapeutics (CKPT) United States $0.349B 0.00
Benitec Biopharma (BNTC) United States $0.320B 0.00
Entrada Therapeutics (TRDA) United States $0.318B 10.35
Olema Pharmaceuticals (OLMA) United States $0.314B 0.00
Emergent Biosolutions (EBS) United States $0.307B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.302B 0.00
Septerna (SEPN) United States $0.298B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.298B 0.00
ATyr Pharma (ATYR) United States $0.292B 0.00
Fulcrum Therapeutics (FULC) United States $0.290B 0.00
XOMA Royalty (XOMA) United States $0.289B 0.00
Prima BioMed (IMMP) Australia $0.270B 0.00
DBV Technologies S.A (DBVT) France $0.269B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Terns Pharmaceuticals (TERN) United States $0.266B 0.00
Aura Biosciences (AURA) United States $0.263B 0.00
Lifecore Biomedical (LFCR) United States $0.258B 0.00
Abeona Therapeutics (ABEO) United States $0.257B 0.00
Cartesian Therapeutics (RNAC) United States $0.257B 0.00
ITeos Therapeutics (ITOS) United States $0.255B 0.00
Allogene Therapeutics (ALLO) United States $0.254B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.253B 0.00
BioStem Technologies (BSEM) $0.252B 10.07
Gossamer Bio (GOSS) United States $0.252B 0.00
Compass Therapeutics (CMPX) United States $0.252B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.252B 51.12
Palvella Therapeutics (PVLA) United States $0.251B 0.00
MaxCyte (MXCT) United States $0.250B 0.00
Monopar Therapeutics (MNPR) United States $0.241B 0.00
Astria Therapeutics (ATXS) United States $0.239B 0.00
ACELYRIN, INC (SLRN) United States $0.238B 0.00
Alumis (ALMS) United States $0.238B 0.00
Candel Therapeutics (CADL) United States $0.237B 0.00
Foghorn Therapeutics (FHTX) United States $0.234B 0.00
Cidara Therapeutics (CDTX) United States $0.234B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.233B 0.00
Atea Pharmaceuticals (AVIR) United States $0.233B 0.00
Third Harmonic Bio (THRD) United States $0.232B 0.00
Bright Minds Biosciences (DRUG) United States $0.229B 0.00
Aardvark Therapeutics (AARD) United States $0.226B 0.00
Rezolute (RZLT) United States $0.224B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.219B 0.00
Amarin (AMRN) Ireland $0.216B 0.00
GENFIT S.A (GNFT) France $0.215B 0.00
Solid Biosciences (SLDB) United States $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
Nuvectis Pharma (NVCT) United States $0.212B 0.00
Neurogene (NGNE) United States $0.210B 0.00
Innate Pharma S.A (IPHA) France $0.204B 0.00
Codexis (CDXS) United States $0.204B 0.00
Actuate Therapeutics (ACTU) United States $0.202B 0.00
Semper Paratus Acquisition (TVGN) United States $0.200B 0.00
Kodiak Sciences (KOD) United States $0.199B 0.00
Design Therapeutics (DSGN) United States $0.199B 0.00
Ocugen (OCGN) United States $0.196B 0.00
Inventiva S.A (IVA) France $0.190B 0.00
CARGO Therapeutics (CRGX) United States $0.185B 0.00
Humacyte (HUMA) United States $0.185B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.183B 0.00
Cardiff Oncology (CRDF) United States $0.177B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.176B 0.00
Annexon (ANNX) United States $0.176B 0.00
Voyager Therapeutics (VYGR) United States $0.175B 0.00
TuHURA Biosciences (HURA) United States $0.174B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.173B 0.00
Prime Medicine (PRME) United States $0.171B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.169B 0.00
AC Immune (ACIU) Switzerland $0.169B 0.00
Anika Therapeutics (ANIK) United States $0.167B 0.00
Molecular Partners AG (MOLN) Switzerland $0.166B 0.00
Adherex Technologies (FENC) United States $0.164B 0.00
Inhibrx Biosciences (INBX) United States $0.162B 0.00
Sangamo Therapeutics (SGMO) United States $0.160B 0.00
INmune Bio (INMB) United States $0.160B 0.00
DiaMedica Therapeutics (DMAC) United States $0.157B 0.00
EnGene Holdings (ENGN) Canada $0.151B 0.00
Galena Biopharma (SLS) United States $0.148B 0.00
BioAge Labs (BIOA) United States $0.145B 0.00
Puma Biotechnology (PBYI) United States $0.144B 3.78
Nkarta (NKTX) United States $0.137B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.136B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.126B 0.00
Greenwich LifeSciences (GLSI) United States $0.125B 0.00
Tango Therapeutics (TNGX) United States $0.123B 0.00
ScPharmaceuticals (SCPH) United States $0.123B 0.00
Editas Medicine (EDIT) United States $0.121B 0.00
Theratechnologies (THTX) Canada $0.120B 0.00
Fate Therapeutics (FATE) United States $0.119B 0.00
Alpha Cognition (ACOG) Canada $0.119B 0.00
Alector (ALEC) United States $0.117B 0.00
Vigil Neuroscience (VIGL) United States $0.113B 0.00
Compugen (CGEN) Israel $0.112B 0.00
Coherus BioSciences (CHRS) United States $0.112B 0.00
Genelux (GNLX) United States $0.112B 0.00
Seer (SEER) United States $0.110B 0.00
EXoZymes (EXOZ) United States $0.109B 0.00
InflaRx (IFRX) Germany $0.108B 0.00
Neumora Therapeutics (NMRA) United States $0.107B 0.00
BioHarvest Sciences (BHST) Canada $0.106B 0.00
C4 Therapeutics (CCCC) United States $0.104B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.102B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.102B 0.00
Coya Therapeutics (COYA) United States $0.101B 0.00
Contineum Therapeutics (CTNM) United States $0.100B 0.00
Sagimet Biosciences (SGMT) United States $0.100B 0.00
Rapt Therapeutics (RAPT) United States $0.100B 0.00
Entera Bio (ENTX) Israel $0.098B 0.00
Immunic (IMUX) United States $0.097B 0.00
HilleVax (HLVX) United States $0.095B 0.00
Black Diamond Therapeutics (BDTX) United States $0.093B 0.00
Kyverna Therapeutics (KYTX) United States $0.091B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.089B 0.00
Nautilus Biotechnology (NAUT) United States $0.088B 0.00
Ventyx Biosciences (VTYX) United States $0.088B 0.00
Cellectis S.A (CLLS) France $0.088B 0.00
Elicio Therapeutics (ELTX) United States $0.088B 0.00
Instil Bio (TIL) United States $0.087B 0.00
Pliant Therapeutics (PLRX) United States $0.087B 0.00
Senti Biosciences (SNTI) United States $0.085B 0.00
Elutia (ELUT) United States $0.085B 0.00
XBiotech (XBIT) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Zura Bio (ZURA) United States $0.083B 0.00
Climb Bio (CLYM) United States $0.080B 0.00
Genenta Science S.p.A (GNTA) Italy $0.079B 0.00
Invivyd (IVVD) United States $0.078B 0.00
Adagene (ADAG) China $0.075B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.075B 0.00
CytomX Therapeutics (CTMX) United States $0.075B 2.44
Inozyme Pharma (INZY) United States $0.074B 0.00
CervoMed (CRVO) United States $0.074B 0.00
Sutro Biopharma (STRO) United States $0.074B 0.00
Exicure (XCUR) United States $0.072B 0.00
MediciNova (MNOV) United States $0.072B 0.00
Caribou Biosciences (CRBU) United States $0.072B 0.00
TScan Therapeutics (TCRX) United States $0.072B 0.00
I-Mab (IMAB) United States $0.072B 0.00
Adlai Nortye (ANL) Cayman Islands $0.068B 0.00
Jasper Therapeutics (JSPR) United States $0.068B 0.00
BeyondSpring (BYSI) United States $0.068B 0.00
IGM Biosciences (IGMS) United States $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.066B 0.00
VTv Therapeutics (VTVT) United States $0.066B 0.00
Inovio Pharmaceuticals (INO) United States $0.066B 0.00
IO Biotech (IOBT) Denmark $0.066B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.066B 0.00
VistaGen Therapeutics (VTGN) United States $0.065B 0.00
Medicus Pharma (MDCX) United States $0.062B 0.00
Agenus (AGEN) United States $0.062B 0.00
Seres Therapeutics (MCRB) United States $0.062B 0.00
Biomea Fusion (BMEA) United States $0.061B 0.00
Citius Oncology (CTOR) United States $0.061B 0.00
ZIVO Bioscience (ZIVO) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Cabaletta Bio (CABA) United States $0.060B 0.00
Alto Neuroscience (ANRO) United States $0.060B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.059B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.059B 0.00
Adverum Biotechnologies (ADVM) United States $0.059B 0.00
Repare Therapeutics (RPTX) Canada $0.058B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Applied Therapeutics (APLT) United States $0.057B 0.00
Skye Bioscience (SKYE) United States $0.056B 0.00
Akoya Biosciences (AKYA) United States $0.055B 0.00
PDS Biotechnology (PDSB) United States $0.055B 0.00
Ikena Oncology (IKNA) United States $0.055B 0.00
Precision BioSciences (DTIL) United States $0.054B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.052B 0.00
Artiva Biotherapeutics (ARTV) United States $0.051B 0.00
Adicet Bio (ACET) United States $0.050B 0.00
Renovaro (RENB) United States $0.050B 0.00
Fortress Biotech (FBIO) United States $0.050B 0.00
PepGen (PEPG) United States $0.049B 0.00
OKYO Pharma (OKYO) $0.049B 0.00
Oncobiologics (OTLK) United States $0.049B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Shattuck Labs (STTK) United States $0.045B 0.00
Quince Therapeutics (QNCX) United States $0.045B 0.00
Oncolytics Biotech (ONCY) Canada $0.045B 0.00
Connect Biopharma Holdings (CNTB) United States $0.045B 0.00
Pluri (PLUR) Israel $0.045B 0.00
Kronos Bio (KRON) United States $0.044B 0.00
Atara Biotherapeutics (ATRA) United States $0.043B 0.00
Opus Genetics (IRD) United States $0.043B 0.00
CAMP4 Therapeutics (CAMP) United States $0.043B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.043B 0.00
TELA Bio (TELA) United States $0.043B 0.00
Alterity Therapeutics - (ATHE) Australia $0.043B 0.00
Forte Biosciences (FBRX) United States $0.042B 0.00
Whitehawk Therapeutics (WHWK) United States $0.042B 0.00
Rani Therapeutics Holdings (RANI) United States $0.042B 0.00
Immuneering (IMRX) United States $0.041B 0.00
Celularity (CELU) United States $0.040B 0.00
Mersana Therapeutics (MRSN) United States $0.040B 0.00
Tvardi Therapeutics (TVRD) United States $0.039B 0.00
RenovoRx (RNXT) United States $0.039B 0.00
Rein Therapeutics (RNTX) United States $0.039B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
Tenaya Therapeutics (TNYA) United States $0.036B 0.00
AN2 Therapeutics (ANTX) United States $0.036B 0.00
Werewolf Therapeutics (HOWL) United States $0.036B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.035B 0.00
Spero Therapeutics (SPRO) United States $0.035B 0.00
Bluebird Bio (BLUE) United States $0.034B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.034B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.033B 0.00
Dyadic (DYAI) United States $0.032B 0.00
Boundless Bio (BOLD) United States $0.032B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.032B 0.00
FibroBiologics (FBLG) United States $0.032B 0.00
Radiopharm Theranostics - (RADX) Australia $0.031B 0.00
Kezar Life Sciences (KZR) United States $0.031B 0.00
Allakos (ALLK) United States $0.030B 0.00
Femasys (FEMY) United States $0.029B 0.00
Cadrenal Therapeutics (CVKD) United States $0.028B 0.00
CalciMedica (CALC) United States $0.028B 0.00
MiNK Therapeutics (INKT) United States $0.028B 0.00
Scilex Holding (SCLX) United States $0.028B 0.00
Grace Therapeutics (GRCE) Canada $0.028B 0.00
Aligos Therapeutics (ALGS) United States $0.027B 0.00
OnKure Therapeutics (OKUR) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
BioAtla (BCAB) United States $0.025B 0.00
Quantum Biopharma (QNTM) Canada $0.025B 0.00
Generation Bio (GBIO) United States $0.024B 0.00
Clene (CLNN) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.023B 0.00
ALX Oncology Holdings (ALXO) United States $0.023B 0.00
KALA BIO (KALA) United States $0.022B 0.00
Annovis Bio (ANVS) United States $0.022B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.021B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Advanced Biomed (ADVB) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Passage Bio (PASG) United States $0.020B 0.00
Elevation Oncology (ELEV) United States $0.020B 0.00
ABVC BioPharma (ABVC) United States $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
Curis (CRIS) United States $0.020B 0.00
X4 Pharmaceuticals (XFOR) United States $0.020B 0.00
Lexaria Bioscience (LEXX) Canada $0.019B 0.00
Q32 Bio (QTTB) United States $0.019B 0.00
Vor Biopharma (VOR) $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
Chemomab Therapeutics (CMMB) Israel $0.018B 0.00
Lisata Therapeutics (LSTA) United States $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.018B 0.00
Kalaris Therapeutics (KLRS) United States $0.018B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.017B 0.00
Cingulate (CING) United States $0.017B 0.00
Beyond Air (XAIR) United States $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
UNITY Biotechnology (UBX) United States $0.016B 0.00
HOOKIPA Pharma (HOOK) United States $0.016B 0.00
Moleculin Biotech (MBRX) United States $0.015B 0.00
BioCardia (BCDA) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
IN8bio (INAB) United States $0.014B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Bolt Biotherapeutics (BOLT) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Synlogic (SYBX) United States $0.013B 0.00
Gelteq (GELS) Australia $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Hoth Therapeutics (HOTH) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Rallybio (RLYB) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Imunon (IMNN) United States $0.012B 0.00
BRIACELL THERAP (BCTX) Canada $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Affimed (AFMD) Germany $0.011B 0.00
LakeShore Biopharma (LSB) China $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
Abpro Holdings (ABP) United States $0.010B 0.00
Athira Pharma (ATHA) United States $0.010B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.010B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Portage Biotech (PRTG) $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
BioXcel Therapeutics (BTAI) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Aytu BioPharma (AYTU) United States $0.008B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
MetaVia (MTVA) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
BioAffinity Technologies (BIAF) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Eyenovia (EYEN) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Evaxion Biotech (EVAX) Denmark $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Polyrizon (PLRZ) Israel $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00